These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 1536527)

  • 1. Clinical significance of phosphate in calcium oxalate renal stones.
    Ohman S; Larsson L; Tiselius HG
    Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():59-63. PubMed ID: 1536527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule.
    Tiselius HG
    Urol Res; 1997; 25(2):153-9. PubMed ID: 9144885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA; Bashir MA; Riordon DR; Nakagawa Y; Coe FL; Grynpas MD
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine composition and stone formation during treatment with acetazolamide.
    Ahlstrand C; Tiselius HG
    Scand J Urol Nephrol; 1987; 21(3):225-8. PubMed ID: 3433023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between kidney stone composition and urinary metabolic disturbances in children.
    Kirejczyk JK; Porowski T; Filonowicz R; Kazberuk A; Stefanowicz M; Wasilewska A; Debek W
    J Pediatr Urol; 2014 Feb; 10(1):130-5. PubMed ID: 23953243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early changes of oxalate and calcium urine excretion in those with calcium oxalate stone formation after extracorporeal shock wave lithotripsy.
    Oehlschläger S; Albrecht S; Hakenberg OW; Schrödter S; Froehner M; Manseck A; Wirth MP
    Urology; 2003 Jul; 62(1):17-21. PubMed ID: 12837412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
    Parks JH; Coe FL; Evan AP; Worcester EM
    Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.